Fig. 3From: Adverse drug effects observed with vildagliptin versus pioglitazone or rosiglitazone in the treatment of patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trialsAdverse drug events reported between vildagliptin and pioglitazone/rosiglitazone (part 2)Back to article page